| Ticker Details |
|
Avanos Medical, Inc.
|
| IPO Date: |
October 20, 2014 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$1.17B |
| Activated in VL: |
False |
| Average Daily Range |
| Avg Daily Range: |
$0.49 | 1.73%
|
| Avg Daily Range (30 D): |
$0.01 | 0.04%
|
| Avg Daily Range (90 D): |
$0.19 | 1.15%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.31M |
| Avg Daily Volume (30 D): |
.17M |
| Avg Daily Volume (90 D): |
1.04M |
| Trade Size |
| Avg Trade Size (Sh.): |
67 |
| Avg Trade Size (Sh.) (30 D): |
142 |
| Avg Trade Size (Sh.) (90 D): |
169 |
| Institutional Trades |
| Total Institutional Trades: |
3,128 |
| Avg Institutional Trade: |
$1.66M |
| Avg Institutional Trade (30 D): |
$3.06M |
| Avg Institutional Trade (90 D): |
$2.61M |
| Avg Institutional Trade Volume: |
.06M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.61M |
| Avg Closing Trade (30 D): |
$3.82M |
| Avg Closing Trade (90 D): |
$3.69M |
| Avg Closing Volume: |
61.45K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$.11
|
$-.03
|
$-1.66
|
|
Diluted EPS
|
$.11
|
$-.03
|
$-1.66
|
|
Revenue
|
$182.2M
|
$177.8M
|
$175M
|
|
Gross Profit
|
$94.2M
|
$86M
|
$92.1M
|
|
Net Income / Loss
|
$5.1M
|
$-1.4M
|
$-76.8M
|
|
Operating Income / Loss
|
$8.9M
|
$.1M
|
$-74.5M
|
|
Cost of Revenue
|
$88M
|
$91.8M
|
$82.9M
|
|
Net Cash Flow
|
$-24.2M
|
$-19.8M
|
$-6.7M
|
|
PE Ratio
|
|
|
|
|
|
|